Fiscal Year 2019 – Record year points to increasing growth dynamics

March 13, 2020
  • Sales pass 300-million mark for the first time at 313.7 million CHF
  • EBIT margin rises to 19.9%, EBITDA margin to 27.8%
  • Net income up sharply to 54.2 million CHF
  • Initial successes in oligonucleotide market
  • Growth targets raised thanks to rising demand
  • Proposed dividend increase to 3.00 CHF per share

Careers

At Bachem, we believe that our employees make the difference. Representing our corporate culture of passion and commitment, they are the foundation of our success. We therefore strive to attract, retain, and develop highly motivated, well-qualified individuals.

View all jobs

Click here >>

Contact us

 

  • Please choose if you would like to receive additional email communications from Bachem:

  • Fields marked with an asterisk (*) are required

  • Hidden
    :
  • Hidden
  • This field is for validation purposes and should be left unchanged.